Biomedical research, a tool to address the health issues that affect African populations

Globalization and Health

Volumn 9, Issue 1, 2013, Pages

  Peprah, Emmanuel ^a   Wonkam, Ambroise ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Africa; Biomedical; Development; Genomics; Policy; Research

Indexed keywords

AFRICA; AFRICAN; ASTHMA; COMMUNICABLE DISEASE; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE TRANSMISSION; EDITORIAL; ETHNICITY; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LUNG DISEASE; MALARIA; MEDICAL GENETICS; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; NEOPLASM; NON COMMUNICABLE DISEASE; PODOCONIOSIS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TUBERCULOSIS; AFRICA SOUTH OF THE SAHARA; GENOMICS; HEALTH CARE DELIVERY;

AFRICA SOUTH OF THE SAHARA; BIOMEDICAL RESEARCH; BIOMEDICAL TECHNOLOGY; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; GENOMICS; HUMANS;

EID: 84885780560     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/1744-8603-9-50     Document Type: Editorial

References (90)

1. McKillop AM, Flatt PR. Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine. Diabetes Care 2011, 34:2624-2630. 10.2337/dc11-0837, 3220869, 22110171.
2. Hardy BJ, Seguin B, Goodsaid F, Jimenez-Sanchez G, Singer PA, Daar AS. The next steps for genomic medicine: challenges and opportunities for the developing world. Nat Rev Genet 2008, 9(Suppl 1):S23-S27.
3. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, Levitz CE, Lopez AD, Murray CJ. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2071-2094. 10.1016/S0140-6736(12)61719-X, 23245603.
4. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, Murray CJ. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012, 380:2144-2162. 10.1016/S0140-6736(12)61690-0, 23245606.
5. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196. 10.1016/S0140-6736(12)61729-2, 23245607.
6. Charle P, Berzosa P, de Lucio A, Raso J, Nseng Nchama G, Benito A. Artesunate/Amodiaquine Malaria Treatment for Equatorial Guinea (Central Africa). Am J Trop Med Hyg 2013, 88:1087-1092. 10.4269/ajtmh.12-0290, 3752807, 23530078.
7. Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME, Ryckman KK, Tacconelli A, Mariani-Costantini R, Novelli G, et al. Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet 2008, 123:557-598. 10.1007/s00439-008-0511-y, 18512079.
8. Wilkin TJ, Gulick RM. CCR5 antagonism in HIV infection: current concepts and future opportunities. Annu Rev Med 2012, 63:81-93. 10.1146/annurev-med-052010-145454, 3298858, 22034870.
9. Di Berardino MA. Animal cloning-the route to new genomics in agriculture and medicine. Differentiation 2001, 68:67-83. 10.1046/j.1432-0436.2001.680201.x, 11686237.
10. Burt DW. Chicken genome: current status and future opportunities. Genome Res 2005, 15:1692-1698. 10.1101/gr.4141805, 16339367.
11. Alwan A, Modell B. Recommendations for introducing genetics services in developing countries. Nat Rev Genet 2003, 4:61-68.
12. World Health Organization. Advisory Committee on Health Research Genomics and world health : report of the Advisory Committee on Health Research 2002, Geneva: World Health Organization, World Health Organization. Advisory Committee on Health Research.
13. Melon CC, Ray M, Chakkalackal S, Li M, Cooper JE, Chadder J, Ke W, Li L, Madkour MA, Aly S, et al. A survey of South-north health biotech collaboration. Nat Biotechnol 2009, 27:229-232. 10.1038/nbt0309-229, 19270665.
14. Singer PA, Daar AS. Harnessing genomics and biotechnology to improve global health equity. Science 2001, 294:87-89. 10.1126/science.1062633, 11588248.
15. Thorsteinsdottir H, Melon CC, Ray M, Chakkalackal S, Li M, Cooper JE, Chadder J, Saenz TW, Paula MC, Ke W, et al. South-South entrepreneurial collaboration in health biotech. Nat Biotechnol 2010, 28:407-416. 10.1038/nbt0510-407, 20458300.
16. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260. 10.1016/S0140-6736(12)61766-8, 23245609.
17. Ray M, Daar AS, Singer PA, Thorsteinsdottir H. Globetrotting firms: Canada's health biotechnology collaborations with developing countries. Nat Biotechnol 2009, 27:806-814. 10.1038/nbt0909-806, 19741634.
18. Singer PA, Court EB, Bhatt A, Frew SE, Greenwood H, Persad DL, Salamanca-Buentello F, Seguin B, Taylor AD, Daer HT, Daar AS. Applying genomics-related technologies for Africa's health needs. Afr J Med Med Sci 2007, 36(Suppl):7-14.
19. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128. 10.1016/S0140-6736(12)61728-0, 23245604.
20. The Global Burden of Disease: 2004 Update. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/.
21. Ekland EH, Fidock DA. Advances in understanding the genetic basis of antimalarial drug resistance. Curr Opin Microbiol 2007, 10:363-370. 10.1016/j.mib.2007.07.007, 2080794, 17709280.
22. Westenberger SJ, Cui L, Dharia N, Winzeler E. Genome-wide nucleosome mapping of Plasmodium falciparum reveals histone-rich coding and histone-poor intergenic regions and chromatin remodeling of core and subtelomeric genes. BMC Genomics 2009, 10:610. 10.1186/1471-2164-10-610, 2801526, 20015349.
23. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511. 10.1038/nature01097, 12368864.
24. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, Hamlin NE, Haas B, et al. The genome of the African trypanosome Trypanosoma brucei. Science 2005, 309:416-422. 10.1126/science.1112642, 16020726.
25. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R, et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442. 10.1126/science.1112680, 1470643, 16020728.
26. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrade LF, Ashton PD, et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358. 10.1038/nature08160, 2756445, 19606141.
27. Webster JP, Oliviera G, Rollinson D, Gower CM. Schistosome genomes: a wealth of information. Trends Parasitol 2010, 26:103-106. 10.1016/j.pt.2009.12.006, 20083437.
28. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP. Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 2010, 3:4. 10.1186/1756-3305-3-4, 2837634, 20181031.
29. Magez S, Radwanska M. African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis. Future Microbiol 2009, 4:1075-1087. 10.2217/fmb.09.65, 19824795.
30. Kappe S, Vaughan A, Boddey J, Cowman A. That was then but this is now: malaria research in the time of an eradication agenda. Science 2010, 328:862-866. 10.1126/science.1184785, 20466924.
31. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009, 41:657-665. 10.1038/ng.388, 2889040, 19465909.
32. Peacock C. Host and parasite genomics, an Australasian perspective. Parasite Immunol 2010, 32:599-606.
33. Ndo C, Simard F, Kengne P, Awono-Ambene P, Morlais I, Sharakhov I, Fontenille D, Antonio-Nkondjio C. Cryptic Genetic Diversity within the Anopheles nili group of Malaria Vectors in the Equatorial Forest Area of Cameroon (Central Africa). PLoS ONE 2013, 8:e58862. 10.1371/journal.pone.0058862, 3597579, 23516565.
34. Miiro GM, Ouwe Missi Oukem-Boyer O, Sarr O, Rahmani M, Ntoumi F, Dheda K, Pym A, Mboup S, Kaleebu P. EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa. BMC Public Health 2013, 13:258. 10.1186/1471-2458-13-258, 3623728, 23517572.
35. Agu PU, Ogboi JS, Akpoigbe K, Okeke T, Ezugwu E. Impact of Plasmodium falciparum and hookworm infections on the frequency of anaemia in pregnant women of rural communities in Enugu, South East Nigeria. Pan Afr Med J 2013, 14:27. 3597852, 23503560.
36. Pang T, Weatherall D. Genomics and global health - Hype, reality, and a call for action in the developing and the developed world. BMJ 2002, 324:1051-1052. 1123014, 11991895.
37. Lustigman S, Geldhof P, Grant WN, Osei-Atweneboana MY, Sripa B, Basanez MG. A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases. PLoS Negl Trop Dis 2012, 6:e1445. 10.1371/journal.pntd.0001445, 3335859, 22545160.
38. Warnich L, Drogemoller BI, Pepper MS, Dandara C, Wright GE. Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation. Curr Pharmacogenomics Person Med 2011, 9:191-207. 10.2174/187569211796957575, 3228231, 22563365.
39. Palermo RE, Fuller DH. Omics Investigations of HIV and SIV Pathogenesis and Innate Immunity. Curr Top Microbiol Immunol 2013, 363:87-116.
40. Cherutich P, Bunnell R, Mermin J. HIV Testing: Current Practice and Future Directions. Curr HIV/AIDS Rep 2013, 10:134-141.
41. Nglazi MD, Kaplan R, Caldwell J, Peton N, Lawn SD, Wood R, Bekker LG. Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. S Afr Med J 2012, 102:936-939.
42. Joska JA, Sorsdahl KR. Integrating Mental Health into General Health Care: Lessons From HIV. Afr J Psychiatry 2012, 15:420-423.
43. Joubert BR, Lange EM, Franceschini N, Mwapasa V, North KE, Meshnick SR. A whole genome association study of mother-to-child transmission of HIV in Malawi. Genome Med 2010, 2:17. 10.1186/gm138, 2873795, 20487506.
44. Petrovski S, Fellay J, Shianna KV, Carpenetti N, Kumwenda J, Kamanga G, Kamwendo DD, Letvin NL, McMichael AJ, Haynes BF, et al. Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS 2011, 25:513-518. 10.1097/QAD.0b013e328343817b, 3150594, 21160409.
45. Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna K, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A, et al. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS One 2011, 6:e28632. 10.1371/journal.pone.0028632, 3236203, 22174851.
46. Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, Gyapong J, Sirugo G, Sisay-Joof F, Enimil A, Chinbuah MA, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010, 42:739-741. 10.1038/ng.639, 20694014.
47. Rezaie R, McGahan AM, Daar AS, Singer PA. Innovative drugs and vaccines in China, India and Brazil. Nat Biotechnol 2012, 30:923-926. 10.1038/nbt.2380, 23051806.
48. Rezaie R, McGahan AM, Frew SE, Daar AS, Singer PA. Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators. Health Res Policy Syst 2012, 10:18. 10.1186/1478-4505-10-18, 3424104, 22672351.
49. McCoy D, Bennett S, Witter S, Pond B, Baker B, Gow J, Chand S, Ensor T, McPake B. Salaries and incomes of health workers in sub-Saharan Africa. Lancet 2008, 371:675-681. 10.1016/S0140-6736(08)60306-2, 18295025.
50. Seguin B, Singer PA, Daar AS. Science community: scientific diasporas. Science 2006, 312:1602-1603. 10.1126/science.1126325, 16778041.
51. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005, 4:2. 10.1186/1475-9276-4-2, 546417, 15651987.
52. Redd SC. Asthma in the United States: burden and current theories. Environ Health Perspect 2002, 110(Suppl 4):557-560. 1241205, 12194886.
53. Lenoir M, McGill CL, Graham LM, Foggs M, Robinson S, Crim C, Stempel DA. A new focus on assessing and treating asthma control in the African-American community: a call to action. J Natl Med Assoc 2008, 100:1-23.
54. Sleiman PM, Flory J, Imielinski M, Bradfield JP, Annaiah K, Willis-Owen SA, Wang K, Rafaels NM, Michel S, Bonnelykke K, et al. Variants of DENND1B associated with asthma in children. N Engl J Med 2010, 362:36-44. 10.1056/NEJMoa0901867, 20032318.
55. Himes BE, Hunninghake GM, Baurley JW, Rafaels NM, Sleiman P, Strachan DP, Wilk JB, Willis-Owen SAG, Klanderman B, Lasky-Su J, et al. Genome-wide Association Analysis Identifies PDE4D as an Asthma-Susceptibility Gene. Am J Hum Genet 2009, 84:581-593. 10.1016/j.ajhg.2009.04.006, 2681010, 19426955.
56. Mathias RA, Grant AV, Rafaels N, Hand T, Gao L, Vergara C, Tsai YJ, Yang M, Campbell M, Foster C, et al. A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol 2010, 125:336-346 e334. 10.1016/j.jaci.2009.08.031, 3606015, 19910028.
57. Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, Graves PE, Himes BE, Levin AM, Mathias RA, Hancock DB, et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nature Genet 2011, 43:887-892. 10.1038/ng.888, 3445408, 21804549.
58. Sebastiani P, Solovieff N, Hartley SW, Milton JN, Riva A, Dworkis DA, Melista E, Klings ES, Garrett ME, Telen MJ, et al. Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol 2010, 85:29-35. 2903007, 20029952.
59. Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, Hooper WC, Bean CJ, Debaun MR, Arking DE, et al. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012, 120:1961-1962. 10.1182/blood-2012-06-432849, 3433099, 22936743.
60. Tekola Ayele F, Adeyemo A, Finan C, Hailu E, Sinnott P, Burlinson ND, Aseffa A, Rotimi CN, Newport MJ, Davey G. HLA Class II Locus and Susceptibility to Podoconiosis. N Engl J Med 2012, 366:1200-1208. 10.1056/NEJMoa1108448, 3350841, 22455414.
61. Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer 2012, 59:386-390. 10.1002/pbc.24175, 22535620.
62. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013, 381:142-151. 10.1016/S0140-6736(12)61229-X, 3547249, 23103089.
63. Weatherall D. Hemoglobinopathies worldwide: present and future. Curr Mol Med 2008, 7:592-599.
64. Wonkam A, Tekendo CN, Sama DJ, Zambo H, Dahoun S, Bena F, Morris MA. Initiation of a medical genetics service in sub-Saharan Africa: experience of prenatal diagnosis in Cameroon. Eur J Med Genet 2011, 54:e399-e404. 10.1016/j.ejmg.2011.03.013, 21473937.
65. Bhatnagar P, Purvis S, Barron-Casella E, DeBaun MR, Casella JF, Arking DE, Keefer JR. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet 2011, 56:316-323. 10.1038/jhg.2011.12, 21326311.
66. Makani J, Menzel S, Nkya S, Cox SE, Drasar E, Soka D, Komba AN, Mgaya J, Rooks H, Vasavda N, et al. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 2011, 117:1390-1392. 10.1182/blood-2010-08-302703, 21068433.
67. Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics 2008, 122:1332-1342. 10.1542/peds.2008-0441, 19047254.
68. Field JJ, DeBaun MR. Asthma and sickle cell disease: two distinct diseases or part of the same process?. Hematology Am Soc Hematol Educ Program 2009, 45-53. 10.1182/asheducation-2009.1.45.
69. Morris CR. Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol 2009, 84:234-241. 10.1002/ajh.21359, 19229984.
70. Caboot JB, Allen JL. Pulmonary complications of sickle cell disease in children. Curr Opin Pediatr 2008, 20:279-287. 10.1097/MOP.0b013e3282ff62c4, 18475096.
71. Ogengo JA, Olabu BO, Ongera D, Sinkeet SR. Pattern of acute myocardial infarction in an African country. Acta Cardiol 2010, 65:613-618.
72. Narh-Bana SA, Chirwa TF, Mwanyangala MA, Nathan R. Adult deaths and the future: a cause-specific analysis of adult deaths from a longitudinal study in rural Tanzania 2003-2007. Trop Med Int Health 2012, 17:1396-1404.
73. Turner ST, Bailey KR, Fridley BL, Chapman AB, Schwartz GL, Chai HS, Sicotte H, Kocher JP, Rodin AS, Boerwinkle E. Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. Hypertension 2008, 52:359-365. 10.1161/HYPERTENSIONAHA.107.104273, 2692710, 18591461.
74. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. The Lancet 2009, 374:934-947.
75. Ramsay M. Africa: continent of genome contrasts with implications for biomedical research and health. FEBS Lett 2012, 586:2813-2819. 10.1016/j.febslet.2012.07.061, 22858376.
76. Nordling L. African nations vow to support science. Nature 2010, 465:994-995. 10.1038/465994a, 20577179.
77. Bateman C. Corruption busting: a real health threat. S Afr Med J 2011, 101:360. 362.
78. Okafor UV. Challenges in critical care services in Sub-Saharan Africa: perspectives from Nigeria. Indian J Crit Care Med 2009, 13:25-27. 10.4103/0972-5229.53112, 2772254, 19881176.
79. Kirigia JM, Barry SP. Health challenges in Africa and the way forward. Int Arch Med 2008, 1:27. 10.1186/1755-7682-1-27, 2615747, 19094201.
80. Lazarus JV, Wallace SA, Liljestrand J. Improving African health research capacity. Scand J Public Health 2010, 38:670-671. 10.1177/1403494810372265, 20529965.
81. Nwaka S, Ilunga TB, Da Silva JS, Rial Verde E, Hackley D, De Vre R, Mboya-Okeyo T, Ridley RG. Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med 2010, 7:e1000293. 10.1371/journal.pmed.1000293, 2893959, 20613865.
82. Wright D, Flis N, Gupta M. The 'Brain Drain' of physicians: historical antecedents to an ethical debate, c. 1960-79. Philos Ethics Humanit Med 2008, 3:24. 10.1186/1747-5341-3-24, 2613146, 19000306.
83. Eastwood JB, Conroy RE, Naicker S, West PA, Tutt RC, Plange-Rhule J. Loss of health professionals from sub-Saharan Africa: the pivotal role of the UK. Lancet 2005, 365:1893-1900. 10.1016/S0140-6736(05)66623-8, 15924988.
84. Agwu K, Llewelyn M. Compensation for the brain drain from developing countries. Lancet 2009, 373:1665-1666. 10.1016/S0140-6736(09)60927-2, 19447243.
85. Ioannidis JP. Global estimates of high-level brain drain and deficit. FASEB J 2004, 18:936-939. 10.1096/fj.03-1394lfe, 15173104.
86. Daar AS, Berndtson K, Persad DL, Singer PA. How can developing countries harness biotechnology to improve health?. BMC Public Health 2007, 7:346. 10.1186/1471-2458-7-346, 2238767, 18053180.
87. Motari M, Quach U, Thorsteinsdottir H, Martin DK, Daar AS, Singer PA. South Africa-blazing a trail for African biotechnology. Nat Biotechnol 2004, 22(Suppl):DC37-DC41.
88. Rotimi CN. Inauguration of the African Society of Human Genetics. Nat Genet 2004, 36:544. 10.1038/ng0604-544, 15167923.
89. Wonkam A, Kenfack MA, Muna WFT, Ouwe-Missi-Oukem-Boyer O. Ethics of human genetic studies in sub-Saharan Africa: the case of Cameroon through a bibliometric analysis. Dev World Bioeth 2011, 11:120-127. 10.1111/j.1471-8847.2011.00305.x, 21781234.
90. Ana JN. Africa's medical brain drain. BMJ 2005, 331:780.